”A new chapter of our story”
Sobi’s Annual Report 2015 is now available online
Click here to read about Sobi’s eventful year
Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients.
Sobi has been involved in the development and manufacturing ofrecombinant protein drugssince the technology was first developed more than30 years ago.
We want to make a differenceto people with rare diseases.
By working closely with patients and their relatives we learn about their daily challenges and needs.
Sobi Interim Report Q1 2016
pdf-format, 1.93 MB
Sobi Q4 and Full Year Report 2015
pdf-format, 3.36 MB
Sobi Interim Report Q3 2015
Sobi Interim Report Q2 2015
pdf-format, 2.49 MB
Sobi Interim Report Q1 2015
pdf-format, 2.33 MB
Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, SwedenPhone: +46 8 697 20 00
© 2013 Swedish Orphan Biovitrum AB (publ) – All rights reserved
Společnost SOBI již dále nenese odpovědnost za obsah ani funkčnost internetových stránek jiných subjektů.
Přejete si opustit stránky?